genetic
-
The Crisis at 23andMe: Can It Go Private, and Does It Still Have Potential?
23andMe, once a pioneer in direct-to-consumer (DTC) genetic testing, is now facing one of the most challenging moments in its history. The company is grappling with financial losses, a rapidly declining stock price, and recently announced a 1-for-20 reverse stock split. This move is seen as a last-ditch effort to stay listed on the Nasdaq Continue reading
-
Unlocking the Molecular Universe: How AlphaFold 3 Could Redefine Blood Analysis and Beyond
AlphaFold 3, developed by Google DeepMind, represents a significant leap forward in the field of molecular biology, particularly in understanding the complex interplay of biomolecules which include proteins, DNA, and RNA. This latest iteration of the AlphaFold series has expanded its capabilities from its predecessor, AlphaFold 2, which already had made substantial strides in protein Continue reading
EssayBoard 